Oct 2, 2026 06:50AM
Aug 13, 2026 07:00AM
Aug 13, 2026 07:00AM
Oct 24, 2025 07:00AM
Oct 24, 2025 07:00AM
Oct 7, 2025 07:00AM
Sep 17, 2025 07:00AM Sagimet reports positive phase 3 acne trial results for partner Ascletis
Sep 17, 2025 07:00AM
Aug 26, 2025 07:00AM
Aug 13, 2025 07:30AM
Aug 11, 2025 06:52AM
Aug 5, 2025 07:00AM
Jun 17, 2025 04:10AM
Jun 9, 2025 07:00AM Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2
Jun 4, 2025 05:56AM
Jun 4, 2025 05:00AM
Jun 3, 2025 07:15PM
May 22, 2025 08:00AM
May 8, 2025 06:00AM
Mar 12, 2025 07:30AM
Feb 19, 2025 08:00AM Sagimet Biosciences Announces Oral Presentation at the MASH Pathogenesis and Therapeutic Approaches Keystone Symposium
Jan 6, 2025 08:00AM
Nov 18, 2024 07:33AM
Nov 14, 2024 08:00AM
Oct 11, 2024 07:00AM
Oct 11, 2024 07:00AM
Oct 4, 2024 05:54AM
Oct 1, 2024 10:24AM Leerink Partners Reiterates Outperform Rating on Sagimet Biosciences Inc (SGMT)
Aug 20, 2024 08:14AM
Aug 14, 2024 08:00AM
May 2, 2024 06:08AM
Jan 22, 2024 08:36AM

334,272 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All